RE:april 22 nature articleHi Testy:
If this is "Nature" magazine, then this should be the current issue on the newstands throughout the USA right now. "Nature" is a widely read publication.
From the abstract, it seems that the topic of this paper is square-on exactly the area that Zenith's technology is focused upon (BRD4). And (supposedly) "we" have a significant headstart in this area - particularly so for drugs that have specificity in their action.
Assuming this is all true, then this article should be very relevant to Zenith and also Resverlogix. I would not be surprised if one or both companies were mentioned therein.
I am going to check newstands for this article. It should be available across the country here in the USA at any well-stocked newstand, I'm guessing. Thank you for posting about it.